Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LERCANIDIPINE vs LEVALBUTEROL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LERCANIDIPINE vs LEVALBUTEROL: Safety Overview

Metric LERCANIDIPINE LEVALBUTEROL
Total FAERS Reports 3,767 1,445
Deaths Reported 248 52
Death Rate 6.6% 3.6%
Hospitalizations 2,249 145
Average Patient Age 65.8 yrs 54.6 yrs
% Female Patients 47.8% 70.8%
FDA Approval Date N/A Apr 26, 2013
Manufacturer N/A Actavis Pharma, Inc.
Route N/A ORAL
Marketing Status N/A Discontinued